Quantitative methods in Donor Management

Similar documents
D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

31 countries (117 registries, 20 national) Increased coverage in countries with regional registries 50% European population Overall >20 million

Deceased donation data in the UK. Paul Murphy National Clinical Lead for Organ Donation United Kingdom

Monitoring of iron in whole blood donors at Sanquin Blood Bank

Cross Border Genetic Testing for Rare Diseases

The health economic landscape of cancer in Europe

Overview of drug-induced deaths in Europe - What does the data tell us?

Sperm donation Oocyte donation. Hong Kong þ Guideline þ þ Hungary þ þ þ þ Israel þ þ þ þ Italy þ þ þ. Germany þ þ þ þ Greece þ þ þ þ

Engagement in language assessment / Regions of Europe

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

THE CVD CHALLENGE IN NORTHERN IRELAND. Together we can save lives and reduce NHS pressures

Overview of European Consumption Databases

Behavioural indicators in men who have sex with men

Department of Biological Standardisation OMCL Network & Healthcare (DBO)

PRE-CONFERENCE ACTIVITIES TUESDAY 4 TH - WEDNESDAY 5 TH SEPTEMBER 2018

Extract from Cancer survival in Europe by country and age: results of EUROCARE-5 a population-based study

Project Meeting Prague

Donor Haemovigilance. Mindy Goldman MD Canadian Blood Services 15 th International Haemovigilance Seminar Feb 20, 2013 Brussels, Belgium

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

Palliative nursing care of children and young people across Europe

Blood supply and blood products: Regulatory issues in the pandemic context

WCPT COUNTRY PROFILE December 2017 SWEDEN

UK bowel cancer care outcomes: A comparison with Europe

Perspectives for information on alcohol use in the EU

WCPT COUNTRY PROFILE December 2017 HUNGARY

Authors: Jennifer Kates (Kaiser Family Foundation), José-Antonio Izazola (UNAIDS), Eric Lief (CSIS).

WCPT COUNTRY PROFILE December 2017 SERBIA

Underage drinking in Europe

Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2010

European status report on alcohol and health Leadership, awareness and commitment

Real Life, Real PD Survey

HEV Update Blood Components. Dragoslav Domanović, European Centre for Disease Prevention and Control (Sweden)

INTRAVENOUS INJECTING DRUG USE.

Design and Analysis of a Cancer Prevention Trial: Plans and Results. Matthew Somerville 09 November 2009

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

Differences make a Difference

EFSA s activities on data collection (Art. 33) and proposal for a new initiative (EUMENU) H. Deluyker Director

Donor vigilance: an international perspective

Injecting trends in Austria including results of a systematic literature review on interventions aiming to influence the route of administration

Weekly Influenza Surveillance Report. Week 11

Smokefree Policies in Europe: Are we there yet?

Present and potential perspectives for information on alcohol use in the EU

Planning an effective HPV vaccination launch: The key indicators for success Joakim Dillner

Key Highlights continued

How to reduce cost of apheresis plasma? First lessons of a benchmarking.

Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Prof Stephen P. Halloran. Update on the NHS Bowel Cancer Screening Programme Focus on BS & FIT

European Partnership for Screening

REPORT ON LAWS AND RECOMMENDATIONS ON DENTAL MERCURY MANAGEMENT IN THE EU

New trends in harm reduction in Europe: progress made challenges ahead

MENTAL HEALTH CARE. OECD HCQI Expert meeting 17 th of May, Rie Fujisawa

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

Authors: Jennifer Kates (Kaiser Family Foundation), Eric Lief (The Stimson Center), Carlos Avila (UNAIDS).

Current levels and recent trends in health inequalities in the EU: Updates from the EU Report

A European Union-wide slaughterhouse baseline survey on the prevalence of Salmonella in slaughter pigs

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018

MENTAL HEALTH IN THE WORKPLACE

Who is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers

Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2011

Perspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU

OPTN/UNOS-Thoracic Organ Transplantation Committee: Proposed Modifications to Adult Heart Allocation

Population- based cancer survival estimates

Deceased Donation - Why Data? Damon C. Scales MD PhD

the high CVD risk smoker

Monthly measles and rubella monitoring report

Screening for Cervical Cancer in Europe

Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results

Yersiniosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods. Epidemiology

Movember Netherlands. Policy Plan

COMMISSION OF THE EUROPEAN COMMUNITIES

Weekly influenza surveillance overview

European Collaboration on Dementia. Luxembourg, 13 December 2006

Access to treatment and disease burden

FOURIER STUDY GREYLOCK PRESS: CTS PRODUCT SAMPLE - FOURIER YES. Did the study achieve its main objective?

Where we stand in EFORT

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

Colorectal cancer. New Zealand s place in the world. Inequities in outcomes? Assoc Prof Diana Sarfati

PROMOTION AND PROTECTION OF ALL HUMAN RIGHTS, CIVIL, POLITICAL, ECONOMIC, SOCIAL AND CULTURAL RIGHTS, INCLUDING THE RIGHT TO DEVELOPMENT

Impact of Testing Strategies to Reduce Transmission Risk for HBV. Ravi Reddy, M Vermeulen South African National Blood Service (SANBS) 29 July 2013

Understanding the spread of HIV among men who have sex with men in Belgium: results from online and on site special surveys

ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY

Outcome of proficiency test on EIA serology

Assessment of sofosbuvir (Sovaldi )

EFSA s Concise European food consumption database. Davide Arcella Data Collection and Exposure Unit

Identifying Europe s information needs for effective drug policy Lisbon, EMCCDA

Perspectives on self-sufficiency of blood-derived therapies. Global evolution and realities. Albert Farrugia

Indicators of suicide among people with serious mental illness

CNAPA Meeting Luxembourg September 2016

Transmission, processing and publication of HBS 2015 data

Nutrient profiles for foods bearing claims

Financing the Response to HIV/AIDS in Low and Middle Income Countries: Funding for HIV/AIDS from the G7 and the European Commission

Case study examining the impact of German reunification on life expectancy

Transcription:

Quantitative methods in Donor Management

Sanquin Blood Supply Foundation The only organisation in the NL authorised to supply blood (products) Not-for-profit organisation Employing approximately 3,000 people working in 5 divisions: Blood Bank Plasma Products Diagnostic Services Research Sanquin staff working with / partly employed at academic centers Reagents

Sanquin Blood Bank - numbers ± 380,000 Donors 2.3% of the total Dutch population (16.8 million) Approximately 800,000 donations per year Mostly whole blood (60%, 2wk walk-in) Plasmapheresis (by appointment) Donation interval Minimum 8 weeks (3/yr women, 5/yr men) Average 11-12 weeks

Research

How about simple calculus? 1 + 1 = 1 1 + 1 = 2 1 + 1 = 3

How about simple calculus? 0.6 1 + 0.7 1 = 1.3 1 0.9 1 + 1.2 1 = 2.1 2 1.3 1 + 1.4 1 = 2.7 3

Research Topics Risk Based Selection Donor Risk vs. Patient Risk Cost-Effectiveness Adverse Events and Reactions in Donors Vasovagal Reactions Iron Status and Metabolism Genetic Variation Donor Base Management Recruitment and Retention Involvement of Minorities

Platelet Inventory Management Theory meets Practice

TTO = 7 days 6 days 5 days 4 days 3 days 2 days 1 day NB: on Sundays and Mondays no production!

Stochastic Dynamic Programming V n (d, x) = Minimal expected Costs Cas over of tomorrow the planning period of n days, starting at day d with inventory x; given a demand b (with chance p) and production k V n 1 (d,x) = (Today s C s (d,x) Production C O (d,x) Costs) min + k b p d (b)v n (d,y(x,b,k)) (Minimal Costs after today) (d, x), k n+1 n 0

Risk Based Selection

Donor deferral Every new donor: screening visit Donor screening at every donation About 10% of all visits lead to deferral, new donors >20% o For donor health o For recipient health Very disappointing for donor Very expensive for blood bank

Donor Deferral Workshop (Amsterdam, 2012): Donations Not Selected / Deferred Donors Not Selected / Deferred 30% 25% 20% 15% 10% 5% 0% Canada Croatia Denmark Zealand Denmark Odense Germany Germany BWH Estonia Finland France Ireland Latvia Netherlands Northern Ireland Portugal Scotland England ABC Centre, USA Sweden-Skane Sweden-Uppsala Austria Belgium Flanders Belgium Wallonia Blood Operators

Screening Condition Yes No Pos Yes, Right Oops, Also Wrong Test Neg Oops, Wrong Yes, Right Again!

Number of deferrals to prevent one case of a Transfusion Transmitted Disease * Disease # Deferrals Hepatitis B 39,760 Hepatitis C 564,600 HIV 352,875 Syfilis 42,772 * De Kort et al., 2014

Donor Base Management

Databases used for research Donor Database (eprogesa, n ±380,000, ±900,000 donations per year): monthly extractions of: o o o o Donors (sex, age, blood group, stopping reasons, height, weight, donation count) Donations (type, date, amount donated) Donor screening data (hemoglobin, blood pressure, reasons for deferral) Etc...

Databases used for research Separate studies o Donor InSight Study (n>30,000) o Kinetics of IroN in Donors o CARDON o Donor Stress homeostasis blood products o Donor Lapse questionnaires o Consultancy research (internal evaluations of Mobile Blood Drive, donor satisfaction, waiting times, etc.)

Donor InSight (DIS) 50,000 donors randomly selected, 31,338 (63%) participated Questionnaires completed from April 2007-April 2009 Socio-Economical Status Ethnicity Nutrition Medical History (health, disease) Physical activity Donor motivation Donation process Adverse reactions Linkage with blood bank data Linkage with medical and disease registries Consent to recontact

Donor InSight 2 In the past years, again 50,000 donors were asked to complete questionnaires: All surviving respondents DIS 1 (n=29,532) New random samples of donors (n=20,468) Data collection has just been completed... 34,823 (69.7%) participated, data are being cleaned

Donor Health

Deferral Rates Low Hb Deferrals as % of Total Deferrals 80.0 60.0 40.0 20.0 0.0 Canada Croatia Germany Germany BWH Estonia Finland France Brittany Eire Latvia Nether - lands N.Ireland Portugal Austria Scotland England ABC - USA Blood Operators %

Prediction of Hb deferral Prediction models were developed for men and women separately Predictors: Age Season Hb previous visit Hb at 2 last visits (Hb)-deferral at last visit Time since last visit Number of donations in the last 2 years ZPP (Zinc ProtoPorphyrin)

Impact study Evaluate effectiveness of prediction models by selective invitation of donors Randomized controlled trial All Dutch Donors, four regions/groups: Group 1 Invited as usual. i.e. without using prediction model Groups 2-4 Interventions for donors in high risk groups: Group 2 Prolongation of donation interval Group 3 Dietary advice Group 4 Both prolongation of donation interval and dietary advice

Patterns of hemoglobin levels Hemoglobin is measured at every visit Hypothesis: different people cope differently with repeated donations: =donation Faster hemoglobin recovery > genetic basis?

Hemoglobin recovery Days after donation

Kinetics of IroN after Donation (KIND)

Depleting iron stores Iron stores Hemoglobin

Hours Days 0 8 24 Day 2 Kinetics of IroN after Donation, KIND Preliminary results 72 Day 4 168 Day 8 336 Day 15 672 Day 29 1344 Day 57 2016 Day 85 4320 Day 180

CARdiovascular risk and DONation (CARDON) Active WB donors (n=633) & new WB donors (n=112) with 2yr follow-up Questionnaire, metabolic factors Sex-specific donation tertiles of: o o o o Lifetime # donations # donations last 2 years # donations last 4 years Donation frequency

Does stress influence blood product quality? Measuring stress during donations oquestions osaliva cortisol ocontinuous blood pressure, heart rate (variability) Participants (189 per group): onew donors o Regular never deferred donors orecently deferred donors Outcomes: oeffects on platelet and coagulation activity in the donor and the blood products

Recruitment and Retention of Donors

Missing Minorities Ethnic minorities are underrepresented in the donor base Different ethnic groups: odifferent diseases o different blood types The more diverse the donor population, the more patients can be helped General recruitment methods: not successful in reaching minority populations

Follow-up on MIMI Blood group phenotyping Dutch minority groups POPULATION Programme for recruitment and Retention DONOR BASE Estimations of future blood needs for minority groups PATIENTS

Return behaviour ± 2,000 donors completed questionnaire Theory of Planned Behaviour Positive feeling about giving blood Yes I can! Self-identity: blood donation is part of who I am Organizational factors o o Feeling pressure to donate Perceived satisfaction with the blood bank Whole blood donors o2-10 donations o>10 donations

Retention results Most strongly associated with donor lapse: Vasovagal reactions Anxiety Fatigue, particularly in men Subjective distress

Donation Process Management Waiting Times; Operational Staffing

Product Form (also Markov Model) R I C This System s Steady State Chances:

Conclusion Virtually all Research in Donor Management is Quantitative However: In Epidemiological Trend Analyses and Prediction Statistical Modelling is an important Tool Operations Research applies Different Mathematical Techniques, e.g. Stochastic Dynamic Programming Cooperation with other Research Groups is mandatory

{ P ( )} /S V n

No Questions?